We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
Cap. Flow
+$552M
Cap. Flow %
5.91%
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$39.4M
3
INTC icon
Intel
INTC
+$29.2M
4
QCOM icon
Qualcomm
QCOM
+$27.6M
5
DHR icon
Danaher
DHR
+$26M

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 19.55%
3 Financials 10.18%
4 Consumer Discretionary 9.32%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DE icon
276
Deere & Co
DE
$169B
$7.09M 0.08%
40,933
+15,564
+61% +$2.68M
PNC icon
277
PNC Financial Services
PNC
$99.6B
$7.07M 0.08%
44,309
+1,955
+5% +$293K
CXO
278
DELISTED
CONCHO RESOURCES INC.
CXO
$6.96M 0.07%
79,436
+6,976
+10% +$503K
TCDA
279
DELISTED
Tricida, Inc. Common Stock
TCDA
$6.94M 0.07%
184,000
-20,000
-10% -$746K
TOO
280
DELISTED
Teekay Offshore Partners L.P.
TOO
$6.94M 0.07%
+4,505,176
New +$6.93M
GIS icon
281
General Mills
GIS
$19.5B
$6.85M 0.07%
127,859
-3,997
-3% -$211K
ENTA icon
282
Enanta Pharmaceuticals
ENTA
$370M
$6.8M 0.07%
110,139
-4,861
-4% -$301K
MCK icon
283
McKesson
MCK
$99.5B
$6.79M 0.07%
49,057
-760
-2% -$107K
A icon
284
Agilent Technologies
A
$38.9B
$6.71M 0.07%
78,609
+4,551
+6% +$358K
SRE icon
285
Sempra
SRE
$59.7B
$6.7M 0.07%
88,388
-13,412
-13% -$984K
EXC icon
286
Exelon
EXC
$48.2B
$6.65M 0.07%
204,382
-6,168
-3% -$200K
PGR icon
287
Progressive
PGR
$125B
$6.57M 0.07%
90,740
+10,666
+13% +$769K
ALK icon
288
Alaska Air
ALK
$5.3B
$6.49M 0.07%
95,796
+70,659
+281% +$4.83M
PBA icon
289
Pembina Pipeline
PBA
$29B
$6.43M 0.07%
173,297
+32,089
+23% +$1.15M
EOG icon
290
EOG Resources
EOG
$74.7B
$6.39M 0.07%
76,335
+22,704
+42% +$1.66M
MSI icon
291
Motorola Solutions
MSI
$70.3B
$6.35M 0.07%
39,432
-16,770
-30% -$2.76M
TWTR
292
DELISTED
Twitter, Inc.
TWTR
$6.3M 0.07%
196,705
+96,793
+97% +$3.18M
XNCR icon
293
Xencor
XNCR
$1.47B
$6.26M 0.07%
+182,152
New +$6.65M
ZBRA icon
294
Zebra Technologies
ZBRA
$12.6B
$6.25M 0.07%
24,481
-15,572
-39% -$3.64M
MRSH
295
Marsh
MRSH
$87.5B
$6.25M 0.07%
56,111
-192
-0.3% -$20.1K
CME icon
296
CME Group
CME
$92.3B
$6.24M 0.07%
31,064
+1,898
+7% +$389K
UNM icon
297
Unum
UNM
$13.8B
$6.19M 0.07%
212,406
+12,830
+6% +$373K
MLM icon
298
Martin Marietta Materials
MLM
$34.3B
$6.17M 0.07%
22,049
+3,653
+20% +$974K
CTMX icon
299
CytomX Therapeutics
CTMX
$708M
$6.16M 0.07%
741,144
+53,311
+8% +$360K
OXY icon
300
Occidental Petroleum
OXY
$54.6B
$6.14M 0.07%
149,087
-51,679
-26% -$2.07M

Similar funds

Candriam SCA's Q4 2019 Portfolio in Review

As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.

  • Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
  • Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
  • Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
  • Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
  • Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
  • Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.

Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.